Interestingly, PD-1 expression on macrophages has been associated with impaired phagocytosis (32), and PD-1/PD-L1 inhibition in preclinical models has been shown to restore macrophage-mediated antigen presentation and promote tumor clearance (33). The gene discussed is CD274; the disease is neoplasm.